Orient EuroPharma Co., Ltd.
4120
Rank in Stocks
#18881
Orient EuroPharma Co., Ltd. (OEP) operates as a global pharmaceutical... Orient EuroPharma Co., Ltd. (OEP) operates as a global pharmaceutical enterprise, engaged in the development and production of various medications. Its portfolio of prescription pharmaceuticals encompasses treatments for a wide array of conditions, such as cardiovascular issues, metabolic disorders, neurological ailments, obstetric and gynecological health, respiratory diseases, andrological concerns, immunological responses, as well as antibiotics and anti-cancer therapies. Beyond prescription drugs, the company offers nutritional and infant care items, including specialized milk formulas and dietary supplements, marketed under the brand names Karihome, Babecare, and Ostricare. Additionally, it supplies health-related supplements, notably Buccotherm-branded thermal water, designed for the management of oral and periodontal conditions. The company's diverse product range extends to skincare, featuring items like essences, creams, lotions, eye creams, facial toners, and skin-repairing treatments available through its AGLab line. It also distributes skincare oils, body lotions, and gels for dry skin under the well-known Bio-Oil brand, and markets children's skincare solutions through the Mister Baby brand. Furthermore, OEP oversees ISISPHARMA, a dermatology laboratory dedicated to the creation and distribution of specialized dermo-cosmetic goods. Orient EuroPharma is actively involved in extensive research and development efforts, with several key compounds in its pipeline. These include Multikine, an immunotherapy treatment for head and neck cancer currently undergoing Phase III clinical trials; NC-6004, a platinum-based micelle chemotherapeutic agent also in Phase III; ASC-J9, a molecular chemical entity targeting androgen receptor degradation, which has successfully finished its Phase IIb clinical study; and 2ccPA, a phospholipid derivative for symptomatic knee osteoarthritis, progressing through Phase I clinical trials. Established in 1982, Orient EuroPharma Co., Ltd. maintains its headquarters in Taipei, Taiwan.
Share Price
$1.34
Last synced: 2026-11-19
Market Cap
$116.06M
Change (1 day)
1.66%
Change (1 year)
-6.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Orient EuroPharma Co., Ltd. (4120)
Category
Healthcare
Dividend history for Orient EuroPharma Co., Ltd. (4120)
Orient EuroPharma Co., Ltd. (stock symbol: 4120) made a total of 18 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $0.86
Dividend yield (TTM) : 9.20%
The sum of all dividends (adjusted for stock splits) is : $0.86
Dividend yield (TTM) : 9.20%
Dividend payments for Orient EuroPharma Co., Ltd. (4120) from 2008 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.12 | 259.12% |
| 2025 | $0.0344 | 12.77% |
| 2024 | $0.0305 | 7.06% |
| 2022 | $0.0285 | -47.50% |
| 2021 | $0.0542 | -11.14% |
| 2020 | $0.061 | 5.06% |
| 2019 | $0.0581 | -29.23% |
| 2018 | $0.0821 | 38.59% |
| 2017 | $0.0593 | 5.99% |
| 2016 | $0.0559 | 8.95% |
| 2015 | $0.0513 | -8.00% |
| 2014 | $0.0558 | -11.63% |
| 2013 | $0.0631 | 56.82% |
| 2012 | $0.0402 | 77.66% |
| 2011 | $0.0227 | 95.32% |
| 2010 | $0.0116 | 6.73% |
| 2009 | $0.0109 | -11.45% |
| 2008 | $0.0123 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.12 | 259.12% |
| 2025 | $0.0344 | 12.77% |
| 2024 | $0.0305 | 7.06% |
| 2022 | $0.0285 | -47.50% |
| 2021 | $0.0542 | -11.14% |
| 2020 | $0.061 | 5.06% |
| 2019 | $0.0581 | -29.23% |
| 2018 | $0.0821 | 38.59% |
| 2017 | $0.0593 | 5.99% |
| 2016 | $0.0559 | 8.95% |
| 2015 | $0.0513 | -8.00% |
| 2014 | $0.0558 | -11.63% |
| 2013 | $0.0631 | 56.82% |
| 2012 | $0.0402 | 77.66% |
| 2011 | $0.0227 | 68.39% |
| 2010 | $0.0135 | -6.56% |
| 2009 | $0.0144 | -19.50% |
| 2008 | $0.0179 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 62.00% |
IL
|
Questions about Orient EuroPharma Co., Ltd.'s dividend per share
What is Orient EuroPharma Co., Ltd.'s dividend per share?
Orient EuroPharma Co., Ltd.'s dividend per share over the last twelve months is $0.12, as of Jul 2026.
What was Orient EuroPharma Co., Ltd.'s dividend per share in 2025?
In 2025, Orient EuroPharma Co., Ltd.'s dividend per share was $0.03, 12.77% more than in 2024 ($0.03).
How has Orient EuroPharma Co., Ltd.'s dividend per share changed since 2020?
From 2020 to 2025, Orient EuroPharma Co., Ltd.'s dividend per share went from $0.06 to $0.03, an average decline of 10.85% a year.